Modera Wealth Management’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-6,425
Closed -$219K – 514
2021
Q4
$219K Buy
+6,425
New +$252K 0.01% 537
2021
Q1
– Sell
-4,770
Closed -$257K – 242
2020
Q4
$257K Buy
+4,770
New +$216K 0.02% 200

Other funds holding NEO

Modera Wealth Management's NEO Position: Q1 2022 in Review

Modera Wealth Management sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 6,425 shares — an estimated $219K sold.

Modera Wealth Management first reported a position in NEO in Q4 2020 and held it in 2 quarters. The position peaked at $257K in Q4 2020. 279 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Modera Wealth Management reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Modera Wealth Management sold 6,425 NeoGenomics shares in Q1 2022, an estimated $219K.
  • Modera Wealth Management first reported a position in NeoGenomics in Q4 2020 and held it in 2 quarters.
  • Modera Wealth Management's NeoGenomics position peaked at $257K in Q4 2020.
  • 279 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Modera Wealth Management's 13F filing for Q1 2022, filed 3 May 2022.